Jean-Sébastien Hulot to Ticlopidine
This is a "connection" page, showing publications Jean-Sébastien Hulot has written about Ticlopidine.
Connection Strength
0.071
-
Platelet reactivity in human immunodeficiency virus infected patients on dual antiplatelet therapy for an acute coronary syndrome: the EVERE2ST-HIV study. Eur Heart J. 2017 Jun 01; 38(21):1676-1686.
Score: 0.038
-
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19. Expert Opin Drug Metab Toxicol. 2015; 11(10):1599-617.
Score: 0.033